🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/11/1987 | 9,36 | 9,81 | 9,34 | 9,70 | +3,83% | 5,03% | 15.432.638 |
| 04/11/1987 | 9,24 | 9,41 | 9,22 | 9,34 | +0,43% | 2,01% | 11.656.066 |
| 03/11/1987 | 9,30 | 9,41 | 9,18 | 9,30 | -2,77% | 2,42% | 14.996.880 |
| 02/11/1987 | 9,54 | 9,73 | 9,49 | 9,57 | -0,55% | 2,50% | 8.339.774 |
| 30/10/1987 | 10,02 | 10,07 | 9,62 | 9,62 | +1,40% | 4,50% | 20.771.150 |
| 29/10/1987 | 8,64 | 9,52 | 8,64 | 9,49 | +9,82% | 10,12% | 14.981.789 |
| 28/10/1987 | 8,24 | 9,01 | 8,24 | 8,64 | +0,93% | 9,33% | 21.506.846 |
| 27/10/1987 | 8,43 | 8,76 | 8,32 | 8,56 | +4,19% | 5,19% | 13.193.482 |
| 26/10/1987 | 8,48 | 8,49 | 8,22 | 8,22 | -4,91% | 3,20% | 15.089.314 |
| 23/10/1987 | 8,53 | 8,70 | 8,48 | 8,64 | -0,15% | 2,56% | 13.989.542 |
| 22/10/1987 | 8,75 | 8,88 | 8,43 | 8,65 | -3,40% | 5,15% | 20.916.403 |
| 21/10/1987 | 8,85 | 8,96 | 8,48 | 8,96 | +6,96% | 5,39% | 25.822.930 |
| 20/10/1987 | 8,48 | 8,96 | 7,79 | 8,38 | -1,25% | 13,75% | 31.544.381 |
| 19/10/1987 | 9,49 | 9,49 | 7,95 | 8,48 | -13,04% | 16,20% | 36.899.870 |
| 16/10/1987 | 10,23 | 10,24 | 9,38 | 9,75 | -3,28% | 8,42% | 30.512.520 |
| 15/10/1987 | 10,07 | 10,34 | 10,07 | 10,09 | -0,52% | 2,63% | 21.091.838 |
| 14/10/1987 | 10,39 | 10,44 | 10,07 | 10,14 | -3,65% | 3,57% | 14.779.944 |
| 13/10/1987 | 10,50 | 10,54 | 10,39 | 10,52 | +1,41% | 1,39% | 11.544.768 |
| 12/10/1987 | 10,52 | 10,58 | 10,24 | 10,38 | -2,13% | 3,15% | 12.214.440 |
| 09/10/1987 | 10,66 | 10,75 | 10,58 | 10,60 | -0,62% | 1,62% | 12.508.718 |
| 08/10/1987 | 10,77 | 10,78 | 10,58 | 10,67 | -1,04% | 1,91% | 9.207.518 |
| 07/10/1987 | 10,67 | 10,80 | 10,60 | 10,78 | +1,18% | 1,86% | 12.531.355 |
| 06/10/1987 | 10,95 | 10,97 | 10,66 | 10,66 | -3,37% | 2,90% | 14.040.475 |
| 05/10/1987 | 11,06 | 11,06 | 10,93 | 11,03 | -0,24% | 1,20% | 9.475.387 |
| 02/10/1987 | 11,08 | 11,12 | 10,96 | 11,05 | -0,24% | 1,44% | 8.696.304 |
| 01/10/1987 | 10,95 | 11,11 | 10,95 | 11,08 | +1,03% | 1,39% | 8.994.355 |
| 30/09/1987 | 10,92 | 11,00 | 10,89 | 10,97 | +0,42% | 0,97% | 10.844.914 |
| 29/09/1987 | 10,89 | 11,13 | 10,88 | 10,92 | +0,61% | 2,25% | 11.861.683 |
| 28/09/1987 | 10,83 | 10,86 | 10,77 | 10,85 | +2,44% | 0,80% | 10.077.149 |
| 25/09/1987 | 10,59 | 10,71 | 10,57 | 10,60 | -0,06% | 1,31% | 8.549.165 |